US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Immunome, Inc. - Common Stock (NQ:IMNM)

21.17 +0.27 (+1.29%)
Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
34 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA... 
Via Benzinga
News headline image
IMNM Stock: The Covid Treatment News That Has Immunome Soaring Today ↗
IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment. 
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results ↗
Following the market opening Tuesday, the Dow traded up 1.32% to 34,409.28 while the NASDAQ rose 0.48% to 14,343.85. The S&P also rose, gaining 0.91% to 4,297.39. The U.S. has... 
Via Benzinga
Topics Stocks
Why Immunome's Stock Is Soaring Today ↗
Immunome Inc (NASDAQ:IMNM) is surging Tuesday morning afte... 
Via Benzinga
Thinking About Buying Stock In Immunome, Axsome Or Etsy? ↗
Immunome Inc (NASDAQ:IMNM) shares are trading higher by 9.25% by $32.28 after the ... 
Via Benzinga
News headline image
Immunome Stock Jumps As COVID-19 Antibody Shows Preclinical Neutralizing Activity Against Delta Variant ↗
Immunome Inc (NASDAQ: IMNM) has announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against COVI-19 Delta variant... 
Via Benzinga
News headline image
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Appoints Andrew Badley, M.D., to COVID-19 Advisory Board
From Immunome, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
News headline image
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors
From Immunome, Inc.
Via Business Wire
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related... 
Via Benzinga
News headline image
Immunome to Present at the Jefferies Virtual Healthcare Conference
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Secures Additional $4.3M Funding From DoD To Develop COVID-19 Antibody Cocktail ↗
Immunome Inc (NASDAQ: IMNM) has secured additional funding of $4.3 million from the Department of Defense (DoD) for the development of an antibody cocktail (IMM-... 
Via Benzinga
News headline image
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports First Quarter 2021 Financial Results
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Raises $27M Via Private Equity Placement At 9% ↗
In addition to encouraging preclinical data from the COVID-19 antibody cocktail announced today, Immunome Inc (NASDAQ: IMNM) has entered into a... 
Via Benzinga
News headline image
Immunome's Stock Jumps On Its Antibody Cocktail Neutralizing Multiple COVID-19 Variants In Animal Studies ↗
Immunome Inc (NASDAQ: IMNM) has announced antibody selection for its IMM-BCP-01 antibody cocktail and shared preclinical data showing that IMM-BCP-01 is... 
Via Benzinga
News headline image
Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Announces $27 Million Private Placement
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Appoints Corleen Roche as Chief Financial Officer
From Immunome
Via Business Wire
News headline image
55 Biggest Movers From Yesterday ↗
Gainers Marlin Business Services Corp. (NASDAQ: MRLN) shares surged 50.7% to close at $21.46 on Monday after the company enters into a definitive agreement to be acquired by... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >